adverse Maternal and Infant Outcomes of Women Who Differ in Smoking Status: E-Cigarette and Tobacco Cigarette Users.
Individual Clinical
Safety
Adverse Effects
Nanninga (2023)
Should we worry about children’s exposure to third-hand by-products generated from electronic nicotine delivery systems?
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Nath (2020)
Early Cardiovascular Risk in E-Cigarette Users: the Potential Role of Metals.
Individual Clinical
Safety
Adverse Effects
Navas-acien (2020)
Prevalence of oral parameters in smokeless tobacco-associated precancer
Individual Clinical
Safety
Adverse Effects
Negi (2019)
a Comparison of Flavorless Electronic Cigarette-Generated aerosol and Conventional Cigarette Smoke on the Planktonic Growth of Common Oral Commensal Streptococci.
Individual Clinical
Safety
Adverse Effects
Nelson (2019)
Comparison of End Tidal Carbon Monoxide Levels between Conventional Cigarette, Electronic Cigarette and heated Tobacco Product among asiatic Smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Nga (2020)
Effects of e-cigarette use on mental health among youths: quasi-experimental evidence from Canada.
Individual Clinical
Safety
Adverse Effects
Nguyen (2022)
Is susceptibility to E-cigarettes among youth associated with tobacco and other substance use behaviors one year later? Results from the PaTh study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Nicksic (2019)
a Comparison of Use Topography and Nicotine Pharmacokinetics among Loose and Portioned Smokeless Tobacco Users.
Individual Clinical
Pharmacokinetics & Abuse Liability; User Topography
Pharmacokinetics
Nighbor (2023)
Comparing Risk Factors for Past 30-day E-cigarette and Combustible Tobacco Use: a Longitudinal analysis of the Texas adolescent Tobacco and Marketing Surveillance Study (2014-2017).
Individual Clinical
Safety
Adverse Effects
Obinwa (2021)